Rationale for combining glutamatergic and cholinergic approaches in the symptomatic treatment of Alzheimer’s disease
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rationale for combining glutamatergic and cholinergic approaches in the symptomatic treatment of Alzheimer’s disease
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 12, Issue 11, Pages 1351-1365
Publisher
Informa UK Limited
Online
2012-12-13
DOI
10.1586/ern.12.124
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Addressing the Alzheimer's disease crisis through better understanding, treatment, and eventual prevention of associated neuropsychiatric syndromes
- (2012) Constantine G. Lyketsos et al. Alzheimers & Dementia
- Vestibular stimulation enhances hippocampal long-term potentiation via activation of cholinergic septohippocampal cells
- (2012) Siew Kian Tai et al. BEHAVIOURAL BRAIN RESEARCH
- Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine - searching for the connections
- (2012) Wojciech Danysz et al. BRITISH JOURNAL OF PHARMACOLOGY
- Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
- (2012) Robert Howard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment With Cholinesterase Inhibitors and Memantine of Patients in the Alzheimer's Disease Neuroimaging Initiative
- (2011) Lon S. Schneider ARCHIVES OF NEUROLOGY
- Huperzine A as Potential Treatment of Alzheimer's Disease: An Assessment on Chemistry, Pharmacology, and Clinical Studies
- (2011) Giang T. Ha et al. CHEMISTRY & BIODIVERSITY
- Tolerability and efficacy of memantine add-on therapy to rivastigmine transdermal patches in mild to moderate Alzheimer's disease: a multicenter, randomized, open-label, parallel-group study
- (2011) Seong Hye Choi et al. CURRENT MEDICAL RESEARCH AND OPINION
- Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before
- (2011) Cesare Mancuso et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Impaired Attention in the 3xTgAD Mouse Model of Alzheimer's Disease: Rescue by Donepezil (Aricept)
- (2011) C. Romberg et al. JOURNAL OF NEUROSCIENCE
- Erratum
- (2011) LANCET NEUROLOGY
- A phase II trial of huperzine A in mild to moderate Alzheimer disease
- (2011) M. S. Rafii et al. NEUROLOGY
- Effects of memantine and donepezil on cortical and hippocampal acetylcholine levels and object recognition memory in rats
- (2011) Jouni Ihalainen et al. NEUROPHARMACOLOGY
- Presynaptic Nicotinic α7 and Non-α7 Receptors Stimulate Endogenous GABA Release from Rat Hippocampal Synaptosomes through Two Mechanisms of Action
- (2011) Stefania Zappettini et al. PLoS One
- Neurochemical Mechanisms of a Novel Alzheimer's Disease Therapeutics on Improvement of Cognition and Depressive Behavior
- (2011) Norifumi SHIODA et al. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
- Evp-6124: Safety, Tolerability And Cognitive Effects Of A Novel A7 Nicotinic Receptor Agonist In Alzheimer'S Disease Patients On Stable Donepezil Or Rivastigmine Therapy
- (2010) Dana Hilt et al. Alzheimers & Dementia
- The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine
- (2010) Csaba Nyakas et al. BEHAVIOURAL BRAIN RESEARCH
- Piracetam Defines a New Binding Site for Allosteric Modulators of α-Amino-3-hydroxy-5-methyl-4-isoxazole-propionic Acid (AMPA) Receptors
- (2010) Ahmed H. Ahmed et al. JOURNAL OF MEDICINAL CHEMISTRY
- Central Cholinesterase Inhibition Enhances Glutamatergic Synaptic Transmission
- (2010) Maxim Kozhemyakin et al. JOURNAL OF NEUROPHYSIOLOGY
- Neurochemical basis for symptomatic treatment of Alzheimer's disease
- (2010) Paul T. Francis et al. NEUROPHARMACOLOGY
- E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat
- (2010) Ian Kendall et al. PSYCHOPHARMACOLOGY
- Dimebon disappointment
- (2010) Roy W Jones Alzheimers Research & Therapy
- Steady-State Pharmacokinetics of Rivastigmine in Patients with Mild to Moderate Alzheimer’s Disease Not Affected by Co-Administration of Memantine
- (2009) Joshua Shua-Haim et al. CLINICAL DRUG INVESTIGATION
- A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer’s disease: a post hoc analysis
- (2009) Martin R. Farlow et al. CURRENT MEDICAL RESEARCH AND OPINION
- Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32)
- (2009) Jason T. Olin et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease
- (2009) O L Lopez et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Long-term Course and Effectiveness of Combination Therapy in Alzheimer Disease
- (2008) Alireza Atri et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Memantine Treatment in Patients with Mild to Moderate Alzheimers Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2008) Anton Porsteinsson et al. Current Alzheimer Research
- Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis
- (2007) S. Gauthier et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease
- (2007) Alireza Kashani et al. NEUROBIOLOGY OF AGING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now